20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bio-Techne Corp (TECH) operates in the Life Sciences Tools & Services industry and is headquartered in Minneapolis, United States with about 3,100 employees. Its market capitalization is roughly $11 billion. In the fiscal year ended 2025-06-30, TECH reported $1.2B in revenue and $73M in net income.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.
Interactive charts & full statements → Open the TECH valuation workbench →
| Income statement | TTM → 2026-03-31 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $931M | $739M | $714M | $643M | $563M | $499M | $452M | $358M | $311M | $315M | $290M | $269M | $264M | $257M | $223M | $203M |
| Gross Profit | $786M | $790M | $770M | $770M | $756M | $633M | $483M | $473M | $432M | $375M | $337M | $307M | $251M | $231M | $236M | $225M | $215M | $208M | $205M | $177M | $157M |
| Gross Margin % | 65.0% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% | 67.5% | 67.9% | 70.3% | 74.4% | 75.0% | 77.6% | 79.8% | 79.0% | 79.5% | 79.1% | 77.4% |
| Operating Income (EBIT) | $154M | $102M | $207M | $299M | $297M | $237M | $157M | $126M | $136M | $122M | $151M | $147M | $160M | $158M | $166M | $163M | $156M | $151M | $144M | $124M | $109M |
| Operating Margin % | 12.7% | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 17.6% | 21.2% | 21.6% | 30.2% | 32.5% | 44.6% | 51.0% | 52.8% | 56.2% | 58.1% | 57.1% | 56.0% | 55.5% | 53.5% |
| Net Income | $110M | $73M | $168M | $285M | $272M | $140M | $229M | $96M | $125M | $77M | $104M | $108M | $111M | $113M | $112M | $112M | $110M | $105M | $104M | $85M | $73M |
| Net Margin % | 9.0% | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.5% | 13.7% | 20.9% | 23.8% | 31.0% | 36.2% | 35.7% | 38.7% | 40.8% | 39.9% | 40.2% | 38.1% | 36.2% |
| EBITDA | $258M | $217M | $313M | $457M | $414M | $250M | $378M | $212M | $201M | $182M | $193M | $184M | $179M | $173M | $175M | $174M | $165M | $159M | $152M | $137M | $115M |
| Earnings Per Share (EPS) | $0.70 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $1.45 | $0.62 | $0.82 | $0.52 | $0.70 | $0.72 | $0.75 | $0.76 | $0.76 | $0.76 | $0.73 | $0.69 | $0.66 | $0.54 | $0.46 |
| Shares Outstanding (M) | 157M | 160M | 161M | 162M | 164M | 162M | 158M | 156M | 152M | 150M | 149M | 149M | 148M | 148M | 148M | 149M | 149M | 152M | 157M | 158M | 158M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $311M | $296M | $287M | $317M | $316M | $297M | $289M | $306M |
| Gross Profit | $208M | $191M | $188M | $199M | $215M | $194M | $183M | $203M |
| Gross Margin % | 66.9% | 64.6% | 65.6% | 62.7% | 67.9% | 65.3% | 63.2% | 66.4% |
| Operating Income (EBIT) | $75M | $54M | $48M | ($24M) | $39M | $47M | $40M | $46M |
| Operating Margin % | 24.2% | 18.4% | 16.6% | -7.5% | 12.2% | 16.0% | 13.8% | 15.0% |
| Net Income | $51M | $38M | $38M | ($18M) | $23M | $35M | $34M | $41M |
| Net Margin % | 16.4% | 12.8% | 13.3% | -5.6% | 7.1% | 11.8% | 11.6% | 13.3% |
| EBITDA | $99M | $78M | $75M | $6M | $68M | $72M | $70M | $72M |
| Earnings Per Share (EPS) | $0.33 | $0.24 | $0.24 | $-0.11 | $0.14 | $0.22 | $0.21 | $0.25 |
| Shares Outstanding (M) | 157M | 157M | 156M | 156M | 159M | 161M | 161M | 161M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-03-31 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $295M | $288M | $299M | $254M | $325M | $352M | $205M | $182M | $170M | $143M | $144M | $139M | $137M | $124M | $127M | $127M | $111M | $111M | $115M | $91M | $86M |
| Capital Expenditures (CapEx) | $25M | $31M | $63M | $38M | $45M | $44M | $52M | $25M | $21M | $15M | $17M | $20M | $14M | $22M | $6M | $4M | $5M | $7M | $16M | $8M | $5M |
| Free Cash Flow (FCF) | $270M | $257M | $236M | $216M | $280M | $308M | $153M | $156M | $149M | $128M | $127M | $119M | $123M | $101M | $121M | $124M | $107M | $105M | $99M | $82M | $81M |
| FCF Margin % | 22.3% | 21.0% | 20.4% | 19.0% | 25.4% | 33.1% | 20.8% | 21.9% | 23.2% | 22.8% | 25.4% | 26.4% | 34.4% | 32.6% | 38.4% | 42.6% | 39.6% | 39.7% | 38.4% | 36.9% | 40.0% |
| Dividends Paid | $50M | $50M | $50M | $50M | $50M | $50M | $49M | $48M | $48M | $47M | $48M | $47M | $45M | $43M | $41M | $40M | $38M | $28M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $87M | $82M | $28M | $98M | $41M | $84M | $64M | $75M |
| Capital Expenditures (CapEx) | $9M | $6M | $5M | $5M | $10M | $7M | $9M | $18M |
| Free Cash Flow (FCF) | $78M | $76M | $22M | $93M | $31M | $78M | $55M | $58M |
| FCF Margin % | 24.9% | 25.9% | 7.8% | 29.4% | 9.8% | 26.1% | 18.9% | 18.8% |
| Dividends Paid | $13M | $12M | $12M | $12M | $13M | $13M | $13M | $13M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B | $2.6B | $2.7B | $2.6B | $2.3B | $2.3B | $2.0B | $1.9B | $1.6B | $1.6B | $1.1B | $1.1B | $862M | $778M | $719M | $618M | $519M | $472M | $507M | $455M | $371M |
| Cash & Cash Equivalents | $210M | $162M | $152M | $181M | $173M | $199M | $147M | $101M | $122M | $92M | $64M | $55M | $319M | $164M | $117M | $78M | $99M | $161M | $167M | $135M | $90M |
| Total Liabilities | $465M | $639M | $635M | $672M | $594M | $692M | $646M | $719M | $514M | $606M | $250M | $216M | $67M | $41M | $45M | $32M | $17M | $16M | $20M | $17M | $30M |
| Total Debt (Short + Long-Term) | $214M | $360M | $332M | $361M | $268M | $353M | $366M | $505M | $348M | $350M | $95M | $77M | $13M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $13M |
| Total Shareholders' Equity | $2.1B | $1.9B | $2.1B | $2.0B | $1.7B | $1.6B | $1.4B | $1.2B | $1.1B | $951M | $879M | $847M | $795M | $738M | $674M | $586M | $502M | $456M | $487M | $438M | $340M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TECH viewer.
About TickerBase · Data methodology & sources